| Primary |
| Drug Use For Unknown Indication |
43.9% |
| Product Used For Unknown Indication |
18.7% |
| Hypertension |
9.6% |
| Essential Hypertension |
5.9% |
| Cardiac Failure |
5.3% |
| Atrial Fibrillation |
3.2% |
| Cardiomyopathy |
2.7% |
| Cardiac Failure Congestive |
1.6% |
| Arrhythmia Supraventricular |
1.1% |
| Coronary Artery Disease |
1.1% |
| Gastritis Prophylaxis |
1.1% |
| Hyperthyroidism |
1.1% |
| Tachycardia Paroxysmal |
1.1% |
| Atrial Flutter |
0.5% |
| Back Pain |
0.5% |
| Cardiac Disorder |
0.5% |
| Carotid Artery Stenosis |
0.5% |
| Coronary Angioplasty |
0.5% |
| Heart Transplant |
0.5% |
| Immunosuppression |
0.5% |
|
| Death |
33.3% |
| Hypotension |
6.9% |
| Loss Of Consciousness |
5.7% |
| Somnolence |
4.6% |
| Vertigo |
4.6% |
| Dermatitis Allergic |
3.4% |
| Disease Progression |
3.4% |
| Myocardial Infarction |
3.4% |
| Psoriasis |
3.4% |
| Suicidal Ideation |
3.4% |
| Transplant Rejection |
3.4% |
| Vision Blurred |
3.4% |
| Visual Impairment |
3.4% |
| Wheezing |
3.4% |
| Cardiac Arrest |
2.3% |
| Fluid Overload |
2.3% |
| Hepatic Encephalopathy |
2.3% |
| Hepatic Function Abnormal |
2.3% |
| Macular Degeneration |
2.3% |
| Monoplegia |
2.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
15.4% |
| Hypertension |
10.9% |
| Product Used For Unknown Indication |
10.4% |
| Supplementation Therapy |
10.0% |
| Parenteral Nutrition |
8.0% |
| Ill-defined Disorder |
6.5% |
| Cardiac Failure |
6.0% |
| Infection |
5.0% |
| Pain |
4.5% |
| Exophthalmos |
3.0% |
| Diabetes Mellitus |
2.5% |
| Prophylaxis |
2.5% |
| Atrial Fibrillation |
2.0% |
| Carcinoid Tumour |
2.0% |
| Inflammation |
2.0% |
| Intraoperative Care |
2.0% |
| Procoagulant Therapy |
2.0% |
| Restlessness |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Conjunctival Haemorrhage |
1.5% |
|
| Loss Of Consciousness |
14.6% |
| Presyncope |
7.3% |
| Stevens-johnson Syndrome |
7.3% |
| Urticaria |
7.3% |
| Vertigo |
7.3% |
| Cardiac Arrest |
4.9% |
| Hyperkalaemia |
4.9% |
| Hypotension |
4.9% |
| Hypothermia |
4.9% |
| Renal Failure Acute |
4.9% |
| Somnolence |
4.9% |
| Systemic Lupus Erythematosus |
4.9% |
| White Blood Cell Count Increased |
4.9% |
| Cardiac Death |
2.4% |
| Chronic Myeloid Leukaemia |
2.4% |
| Hypoglycaemia |
2.4% |
| Hypoglycaemic Unconsciousness |
2.4% |
| Intracranial Haematoma |
2.4% |
| Lung Induration |
2.4% |
| Muscle Contractions Involuntary |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.8% |
| Hypertension |
16.6% |
| Drug Use For Unknown Indication |
15.4% |
| Prophylaxis Against Renal Transplant Rejection |
9.5% |
| Prophylaxis Against Transplant Rejection |
4.5% |
| Surgery |
3.8% |
| Prophylaxis |
3.8% |
| Diabetes Mellitus |
3.5% |
| Coronary Artery Disease |
2.9% |
| Atrial Fibrillation |
2.5% |
| Cardiac Failure |
2.4% |
| Hyperparathyroidism |
2.0% |
| Hyperparathyroidism Secondary |
1.9% |
| Hypercholesterolaemia |
1.8% |
| Medical Diet |
1.5% |
| Myocardial Ischaemia |
1.3% |
| Anaemia |
1.2% |
| Abdominal Pain |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Cardiac Failure Congestive |
1.1% |
|
| Renal Failure Acute |
12.1% |
| Pyrexia |
11.1% |
| Rhabdomyolysis |
6.8% |
| Thrombocytopenia |
5.8% |
| Renal Failure Chronic |
5.3% |
| Vomiting |
5.3% |
| Aortic Dissection |
4.7% |
| Hypoglycaemia |
4.7% |
| Myocardial Infarction |
4.2% |
| Transient Ischaemic Attack |
4.2% |
| Cardiac Arrest |
3.7% |
| Death |
3.7% |
| Respiratory Failure |
3.7% |
| Sepsis |
3.7% |
| Urinary Tract Infection |
3.7% |
| Ventricular Tachycardia |
3.7% |
| Weight Decreased |
3.7% |
| Wound Dehiscence |
3.7% |
| Hypertension |
3.2% |
| Renal Failure |
3.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
30.0% |
| Acute Coronary Syndrome |
10.0% |
| Atrial Flutter |
10.0% |
| Cardiac Failure Chronic |
10.0% |
| Gout |
10.0% |
| Hypercholesterolaemia |
10.0% |
| Ischaemic Heart Disease Prophylaxis |
10.0% |
| Thrombosis Prophylaxis |
10.0% |
|
| Hypotension |
33.3% |
| Renal Failure Chronic |
33.3% |
| Sinus Bradycardia |
33.3% |
|
